“Making money in the market is really about investors with confidence taking it from those that lack it. Knowing that insiders are buying and not selling gives me that added confidence”, Harvey Sax, Top 10 long short equity fund manager according to BarclayHedge
Fibrogen CEO Conterno bought 27,800 shares at $35.47. After last year’s unexpected passing of founder and long-time helmsman Thomas Neff, FibroGen needed a permanent successor—and with its big…
We use cookies to ensure that we give you the best experience on our website. By accessing this site, you agree to be bound by the terms of service, copyright disclaimer and privacy notice. OkPrivacy policy